# FDA Inspection 1233990 - Regenerative Biologics, Inc. - March 11, 2024

Source: https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/f1ea39b8-e874-4d02-be84-b83aa2b1bcfb
Source feed: FDA_Inspections

> FDA Inspection 1233990 for Regenerative Biologics, Inc. on March 11, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1233990
- Company Name: Regenerative Biologics, Inc.
- Inspection Date: 2024-03-11
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1019849 - 2017-06-13](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/0146d026-dbcd-42df-91ff-cd7529db9c98)

Company: https://www.keypedia.com/companies/regenerative-biologics-inc/cd346cf9-62bc-40da-b8c4-a9abc19665d6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d